NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









immunitoAI

immunitoAI

Private
BangaloreHealthcare & Life Scienceshttps://www.immunitoai.com/

Last Round

Series A

Nov 26, 2025

Total Funding Raised

$7.16M

Company Overview

immunitoAI is a biotechnology company that has developed an AI-powered platform for antibody discovery intended to accelerate the development of novel antibody therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

generative AIantibody discoveryde novo antibody designAI drug discoveryantibody therapeuticsTechBiogenerative biologycomputational drug designin silico drug discoverywet lab validationbiologics discoverycustom antibody developmentantibody engineeringaffinity maturation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

immunitoAI Comparables

Compare immunitoAI with similar companies based on industry and business-model similarity.

immunitoAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Antiverse
88%
DenovAI Biotech
86%
Aureka
85%

immunitoAI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 26, 2025
SeedSep 8, 2021
Pre SeedNov 1, 2020

Key People

Founding team and executive leadership

Trisha Chatterjee

Co-Founder and CTO

Founding Team

Aridni Shah

Co-founder and CEO

Founding Team

immunitoAI Investors

Notable investors and investment history

immunitoAI investors
InvestorRounds
LetsVenture OnlineSeries A
pi VenturesSeries A, Seed
3one4 CapitalSeries A
Entrepreneurs FirstSeed, Pre Seed
AC VenturesSeries A
Anicut CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Monthly visitors increased 169% MoM, reaching 11.9K.

  • Jan 6, 2026

    Monthly visitors increased 513% MoM, reaching 4.4K.

immunitoAI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

immunitoAI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about immunitoAI's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore
Employee Range23
Year Founded2020
Last FundingNov 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.